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Summary.-The effect of a single treatment with 30 mg dimethylnitrosamine
(DMN) and 6 ,ug actinomycin D (ACT), given at different time intervals (ACT applica-
tion to DMN, 2 h before, simultaneously, 5, 9 or 48 h later), was tested in female
Sprague-Dawley rats in relation to renal carcinogenesis; additionally, the animals
were fed either a normal or a protein deficient diet.
The ACT treatment did not significantly modify either the kidney tumour in-
cidence or the survival time in the different groups fed a normal diet. Nevertheless,
there are indications that additional ACT application may shorten the latency period
for DMN induced renal neoplasms or, when administered 5 h later than DMN, a
slightly decreased and delayed tumour induction can be assumed. In groups fed a
protein deficient diet, a significantly higher percentage of kidney tumour bearing
animals as well as a shortened latency period were found when compared with the
DMN group on normal diet, but these differences were independent of the additional
ACT treatment 9 h later than DMN and were due to the protein deprivation. Morpho-
logically, the tumours were of epithelial and mesenchymal type with a clear pre-
ponderance of the former type. Biochemical and morphological aspects are dis-
cussed.
THE DEVELOPMENT of tumours in mary neoplasms in rats induced by the
some animal species exposed to carcino- same compound (Anderson and Kellen,
genic substances may be modified by 1971; Gardner, Kellen and Anderson,
secondary treatments. The antibiotic 1973; Tominaga, Taguchi and Shiba,
actinomycin D (ACT), which can bind to 1973). Stewart and Magee (1973), how-
DNA and inhibit the DNA dependent ever, have shown that in protein depleted
RNA synthesis (Kirk, 1960; Kersten, rats ACT did not modify the incidence of
Kersten and Rauen, 1960; Reich et al., dimethylnitrosamine (DMN) induced renal
1961; Flamm, Banerjee and Counts, 1966; tumours but did affect the survival time of
Stewart and Farber, 1968; Bates et al., rats bearing the tumours.
1968; Hennings et al., 1968; Threlfall and As a continuation of this experiment,
Taylor, 1969; Krugh, 1972), inhibits the the effect of a single treatment with DMN
induction of skin tumours in mice by and ACT in different combinations was
7,12-dimethylbenz(a)anthracene (DMBA) studied in rats with regard to renal
(Gelboin, Klein and Bates, 1965; Hennings carcinogenesis. Additionally, either a
and Boutwell, 1967; Bates et al., 1968) normal or a protein deficient diet was fed
and also reduces the incidence of mam- since protein depletion is known to in-
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fluence the toxicity and the carcinogenic chi-square test, and for the incidence of
effect of DMN by inhibition of the drug kidney tumours per animal as well as the
metabolizing enzymes in the liver average survival times in the various groups,
(McLean and Verschuuren, 1969; McLean the U-test after Mann and Whitney (1947)
and Magee, 1970). were performed.
MATERIALS AND METHODS RESULTS
Three hundred and thirty female Sprague- Table I summarizes information on
Dawley rats (Wiga, Sulzfeld, FRG) 12-14 the tumour bearing animals, the average
weeks old were divided into 11 equal groups survival rates as well as the tumour
of30 animals and housed 5 rats per Makrolon incidence of all organs in the different
cage, Type III (E. Becker and Co., Castrop- treatment groups.
Rauxel, FRG) under standard laboratory No kidney tumour was observed in
conditions (temperature, 22 ± 2°C; relative saline treated control animals either with
humidity, 55 + 5%; air exchange, 8 times/h) normal or protein deficient diet (Groups 1
and given water ad libitum. The treatment
groups are listed in Table I. Groups 1-3 and 8) and after treatment with ACT and
were treated i.p. with 1 ml saline/kg body normal diet (Group 3). In Group 10
weight (b.w.) as vehicle controls, 30 mg (ACT, protein deficient diet) only one
DMN (synthesized by F. W. Kruger, DKFZ, kidney neoplasm was diagnosed after 120
Heidelberg, purity, 99.6%) per kg b.w. weeks. In all other DMN treated groups,
dissolved in saline or 6 ,ug ACT (Sigma numerous renal tumours were found.
Chemicals, USA) per kg b.w. alone; Groups Moreover, tumours of organs other than
4-7 received the treatment combinations of the kidney were detected, mainly of the
DMNandACTandwerefedasGroups 1-3with mammary gland (fibromata, fibrosarco-
a normal diet (Hope Farms, RMH-TMB,
Woerden, Holland); in Group 4, ACT was mata, fibroadenomata, carcinomata and
given 2 h before DMN, in Groups 5, 6 and 7, a few carcinosarcomata), the lymphatic
ACT was injected simultaneously 5 h or 48 h system (malignant lymphomata, reticu-
after DMN. In Groups 8-11 the treatment losarcomata and thymomata), the nasal
with saline, DMN and ACT alone or DMN and paranasal cavities (papillomata,
and ACT 9 h later were combined with a squamous and adenocarcinomata, esthe-
protein deficient diet (Hope Farms RMH- sioneuroepitheliomata), the heart (neu-
TMB/McLean and McLean, 1966). The diet rofibromata and one neurofibrosarcoma),
was given 1 week before and 1 week after the adrenal gland (cortical adenomata) as
treatment. well as other various organs (Table I).
All animals died spontaneously or were A s killed when moribund. Except for a few Averae survval t mes and tumourdci-
animals lost through cannibalism, all were dence in Group 3 (ACT, normal diet), completely autopsied, the organs fixed in 4% Group 8 (NaCl, protein deficient diet) and
buffered formalin and processed for routine Group 10 (ACT, protein deficient diet) are
histological examination. Eight graded his- comparable with the control Group 1
tological sections were made from each (NaCl, normal diet), except for the
kidney. The effective number of animals occurrence of one kidney (tubular carci-
(Table I) is based on the number of rats noma) and one coronary (neurofibro-
surviving after the first tumour of any site sarcoma) tumour in Group 10, usually
(28 weeks) had been observed. For statis- seen only in the DMN treated groups.
tical evaluation according to the method of
Cutler and Ederer (1958), the percentage of e doe oACT used ln the present
kidney tumour bearing animals was calcu- experiment was much less than that
lated in 4-week intervals and cumulated required to produce acute toxic symptoms
(cumulative per cent, Fig. 1, 2). For statis- or to induce tumours (Svoboda, Reddy
tical comparison of the kidney tumour and Harris, 1970).
bearing animals in the different groups, the In Table II the detailed results of580 J. HILFRICH ET AL.
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TABLE II. Kidney Tumou,rs Induced in Female Sprague-Dawley Rats after Treatment
with DMN, ACT and Protein Deficient Diet in Different Combinations
Average
survival of Total no. Kidney tumours
Treatment groups TBA* TBA in weeks Bilateral of kidney
(losage per kg b.w., i.p.) (o%) (range) TBA tumours Ratio Epithelial MIesenchymal
1. NaCi (control)
2. DMN 10 (43-4) 94-5 (74-113) 4 21 2-10 21
3. ACT - _ - - -
4. ACT + DMN (2 h) 14 (58 3) 81-5 (48-107) 7 24 1-71 24
5. DAIN + ACT (simult.) 13 (56-5) 86-4 (48-127) 3 21 1-62 18 3
6. DMN + ACT (5 h) 8 (30 8) 100-1 (73-128) 2 13 1-63 13
7. DMN + ACT (48 h) 15 (57 7) 85 9 (42-120) 7 26 1-73 23 3
8. NaCl + prot. def. diet - -
9. DMIN + prot. def. diet 30 (100) 69-8 (47-96) 26 93 3-10 88 5
10. ACT + prot. def. diet 1 (3 8) 120 1 1l00 1
11. DMIN + ACT (9 h) 24 (92.3) 65-4 (33-118) 17 61 2-54 54 7
prot. def. diet
* Kidney tuimouir bearing animals.
kidney tumour incidence in the different 44th or 52nd week after beginning treat-
groups are listed. The renal neoplasms, ment. For the period from the 64th until
which occurred bilaterally in a certain the 72nd week, these 3 groups demon-
number of animals, showed a clear strated a significantly higher cumulative
preponderance of epithelial over mesen- percentage of rats with renal neoplasms
chymal tumours in all groups. compared with Group 2. An exception to
Comparing the percentage of kidney the 3 aforementioned combination groups
tumour bearing animals of Group 2 was made by Group 6 (DAIN, ACT 5 h
(DMN, normal diet) with those in each later). In this group, the first tumour was
other group treated with DMN, ACT and seen at the same time as in Group 2 but
normal diet (Groups 4-7), no significant subsequently the cumulative percentages
difference (P > 0.05) was found. How- are remarkably lower than in the DMN
ever, in Groups 9 and 11 (DMN or DMN Group 2. This difference was statistically
and ACT with protein deficient diet), the significant only for the period from 112
incidence of 100% and 9288%, respec- to 116th weeks of the survival time;
tively, of kidney tumour bearing animals however, for the periods from 92nd to
was significantly increased (P < 0.01) 96th and 104th to 112th weeks borderline
compared with Group 2. values (0G1 > P > 0.05) were found.
Since comparison of the number or The shortened latency period for
percentage of tumour bearing animals induction of kidney tumours in Groups 4,
based on the initial number of rats can be 5 and 7 was not statistically significant
misleading if deaths due to causes other (P > 0 1) in comparison with Group 2.
than the observed tumours occurred at In Fig. 2 Groups 9 and 11 (which
different rates in the various experimental received protein deficient diet and DMN
groups, the cumulative percentage for rats or DMN and ACT 9 h later) are plotted in
with renal neoplasms has been calculated relation to Group 2. For the period from
in 4-week intervals (Cutler and Ederer, the 52nd (Group 9) or 44th week (Group
1958). In Fig. 1 the results for Group 2 11) until the 104th (Group 9) and 100th
(DMN, normal diet) and Groups 4-7 (Group 11) ofthe survival time, significant
(combined treatment of DMN and ACT, differences between the cumulative per-
normal diet) are plotted. While in Group centages were found. Here, the shortened
2 the first renal neoplasm was seen in the latency period for renal tumour induction
76th week, in Groups 4, 5 and 7 the first was highly significant (0 001 < P <
renal tumours appeared as early as in the 0 002).582 J. HILFRICH ElT AL.
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Fio. I -Cumulative percentage of kidney tuimour bearing animals in relation to the survival time
after treatment with DMN alone or DMN and ACT in different combinations; these rats received
a normal diet.
Differences in kidney tumour inci- chymal tumours could be diagnosed (Fig.
dences per animal in Groups 4-7 as well as 5). The morphological patterns of the
9 and 11 failed to be statistically signifi- renal neoplasms were similar for all groups.
cant when compared with the incidence Among the other types of tumours,
per animal in the DMN Group 2. Only for marked differences were observed only for
Group 6 (DMN, ACT 5 h later; normal nasal cavity and heart tumours, which
diet) was a borderline value (0.1 > P > occurred mainly in those groups receiving
0.05) obtained. DMN and ACT in different combinations
Macroscopically, the induced kidney (Groups 4, 5, 6, 9 and 11). Since a single
tumours showed mostly grey-white dosage of 30 mg DMN can induce also
nodules (Fig. 3), increasing in size with a nasal cavity (Montesano et al., 1974) and
tendency to necroses and haemorrhages. neurogenic coronary tumours (Haas, Hil-
In one kidney up to 5 tumours were found. frich and Mohr, 1974), it seems that in
Pulmonary metastases were observed only relation to the average survival time, only
rarely. Histologically, the renal neo- the induction of nasal cavity neoplasms
plasms were predominantly tubular adeno- in Group 11 (DMN, ACT and protein
mata and carcinomata with expansive deficient diet) was slightly increased
growth (Fig. 4); in a few cases, mesen- (Table I).RENAL CARCINOGENICITY OF DIMETHYLNITROSAMINE 583
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FIG. 2.-Cumulative percentage of kidney tumour bearing animals in relation to the survival time
after treatment with DMN or DMN and ACT as well as a protein deficient diet. For comparison,
additionally Group 2, DMN alone, normal diet, is plotted.
FIG. 3.-Bilateral multiple renal tumours (53 weeks, DMN and protein deficient diet). x I6.584 J. HILFRICH ET AL.
FIG. 4.-Part of a tubular kidney carcinoma with expansive growth. H. and E. x 120.
FIG. 5.-Mesenchymal neoplasm of the kidney, within the tumour tissue a retained and not-exten-
sively affected glomerulum. H. and E. x 340.RENAL CARCINOGENICITY OF DIMETHYLNITROSAMINE 585
DISCUSSION latency period in protein deprived rats.
The present studies only partially The most obvious exception in the
confirm the findings of Stewart and results is made by Group 6, which
Magee (1973), who claimed that ACT did received DMN and ACT 5 h later together
not modify the incidence of DMN induced with a normal diet. Though, in com-
renal tumours but did significantly shorten parison with Group 2, no clearlysignificant
the survival time of tumour bearing rats differences could be demonstrated, a
fed a protein deficient diet. In those rats possible effect upon the time of appear-
fed a normal diet and treated with ACT ance as well as the total incidence of renal
2 h before or 48 h after DMN as well as neoplasms in this group cannot be ex-
ACT simultaneously with DMN (Groups 4, cluded. The time of ACT injection 5 h
5 and 7), a remarkably shortened latency later than DMN is possibly the causal
period for the induction ofkidney tumours factor for the "delayed" and " de-
was observed; but comparing the average creased " kidney tumour development.
survival times of animals with renal Stewart and Magee (1973) could demon-
neoplasms in these 3 groups with Group 2 strate that a single dose of ACT adminis-
(DMN alone, normal diet) no statistically tered 24 h after DMN can inhibit the
significant difference was found, even stimulated renal DNA synthesis following
though the cumulative percentage around the application of DMN; however, this
the 70th week was statistically higher in inhibition was dose-dependent and the
these 3 groups. It was suggested that dosage of 12 ,ug/kg b.w. ACT (double our
possibly the known inhibitory effect of dose) was insufficient to prevent DMN
ACT on the immune response (Wust, Gall stimulated DNA synthesis. Similarly,
and Novelli, 1964) may shorten the using a higher ACT dosage (25 ,tg/kg
latency period for the induction of kidney b.w.) than in this study, Threlfall and
tumours (Stewart and Magee, 1973). Taylor (1969) found a very marked
The differences in absolute percentages of depression of DNA synthesis in the
kidney tumour bearing animals in the 3 kidney when ACT was administered
aforementioned combination groups were between 0 and 4 h after folate; with
higher but not statistically significant to longer intervals, this depression became
Group 2. less marked and after 20 h no effect was
In rats deprived of protein (Groups 9 observed. Accordingly, the low ACT dose
and 11) and treated with either DMN or used in the present study failed to have
DMN and ACT, a significantly increased such an effect and the possibly reduced
kidney tumour incidence and shortened and delayed tumour induction in this
latency period were found compared with group might be related to other factors,
Group 2. However, contrary to the e.g., perhaps discrete biochemical reactions
findings of Stewart and Magee (1973), in the kidney at this time of ACT applica-
here the additional ACT treatment 9 h tion after DMN.
after DMN neither remarkably modified The morphological aspects of the renal
the incidence of renal neoplasms, nor the neoplasms reported here were analogous
latency period nor the survival time. to those previously described by various
The deficiency of protein depresses the authors (Magee and Barnes, 1962; Riopelle
activity of the enzyme system in the liver and Jasmin, 1969; Hard and Butler,
that metabolizes DMN to a toxic and 1970; Stewart and Magee, 1973). It is
carcinogenic alkylating agent, whereas noteworthy that in this experiment nearly
the metabolism in the kidney is not 100% epithelial neoplasms were found in
considerably altered (McLean and Magee, the kidney while the above mentioned
1970; Stewart and Magee, 1971). It is authors observed a very high percentage
assumed that this fact explains the higher of mesenchymal renal tumours after
kidney tumour incidence and shortened DMN treatment. As the route of DMN586 J. HILFRICH ET AL.
administration was the same as in the
cited experiments, it can be suggested
that, excluding rat strain differences, the
age of the animals at treatment is prob-
ably decisive for the induction of either
mesenchymal orepithelialkidneytumours.
Using 5- and 5-7 week old rats Hard and
Butler (1970) and Stewart and Magee
(1973), respectively, observed after single
injections of between 30 and 60 mg/kg
b.w. DMN that more than 50% of all
renal tumours were of mesenchymal
origin. In reference to our findings after
DMN treatment in 12-14 week old rats, it
seems that in younger rats the mesen-
chymal tissue is more sensitive to a
carcinogenic effect of DMN while the
tubular cells are more " responsive " in
older animals. Moreover, in all of these
experiments additional treatments of pro-
tein depletion and/or ACT application
did not remarkably change the induction
ofeither epithelial or mesenchymal kidney
tumours.
We are grateful to Naoma Crisp-
Lindgren for her assistance with the
manuscript.
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